Strong ramp-up in its newer facilities reflect the growing demand for high-end institutional healthcare facilities
Lekha Badlani-Jhamnani
February 15, 2023 / 10:01 AM IST
PRO Only Highlights
– Quarterly performance largely backed by improved realisations
– Medium-term triggers China plus and protectionist measures for tyre industry
– Valuations not inexpensive; but improved medium-term outlook
– Quarterly performance largely backed by improved realisations
– Medium-term triggers China plus and protectionist measures for tyre industry
– Valuations not inexpensive; but improved medium-term outlook
Highlights: Top-line growth helped by in-patient volumes and ARPOB Higher operating expenses weighed on margins Plans to add more than 1,000 beds in 24 months Bulk of expansion is brownfield in nature & hence lower capex intensity Valuation at discount to peers Global Health Ltd (GHL), popularly known by its brand name Medanta (CMP: Rs 457; Market Cap: Rs 12,258 crore) posted good Q3FY23 results, overall, with the major contribution coming from the new developing hospitals of Lucknow and Patna. It is one of the largest…
